ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

Shubik Group Finishes Criteria, Presents Final Draft To Rauscher

July 2, 1976

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999